Loading...
XNASNXGLW
Market cap23mUSD
Jan 10, Last price  
0.71USD
1D
8.46%
1Q
50.00%
IPO
-17.06%
Name

Nexgel Inc

Chart & Performance

D1W1MN
XNAS:NXGLW chart
P/E
P/S
1.17
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
0.38%
Rev. gr., 5y
13.06%
Revenues
4m
+99.66%
2,152,0001,992,0002,213,000717,000674,0001,551,0002,048,0004,089,000
Net income
-3m
L-48.62%
-1,776,000-953,000-1,888,000-1,923,000-2,282,000-6,308,000-6,144,000-3,157,000
CFO
-3m
L+8.16%
-1,317,000-777,000-1,544,000-1,814,000-1,801,000-2,753,000-2,992,000-3,236,000

Profile

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.
IPO date
Dec 22, 2021
Employees
12
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
4,089
99.66%
2,048
32.04%
Cost of revenue
7,216
4,975
Unusual Expense (Income)
NOPBT
(3,127)
(2,927)
NOPBT Margin
Operating Taxes
1,398
Tax Rate
NOPAT
(3,127)
(4,325)
Net income
(3,157)
-48.62%
(6,144)
-2.60%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
558
222
Long-term debt
4,200
3,661
Deferred revenue
Other long-term liabilities
Net debt
2,058
(2,726)
Cash flow
Cash from operating activities
(3,236)
(2,992)
CAPEX
(696)
(96)
Cash from investing activities
4,456
(5,595)
Cash from financing activities
379
(3,662)
FCF
(4,125)
(4,393)
Balance
Cash
2,700
6,609
Long term investments
Excess cash
2,496
6,507
Stockholders' equity
(14,240)
(11,552)
Invested Capital
22,204
21,220
ROIC
ROCE
EV
Common stock shares outstanding
5,672
5,575
Price
2.13
70.40%
1.25
-52.11%
Market cap
12,081
73.37%
6,969
-52.09%
EV
14,608
4,243
EBITDA
(2,684)
(2,626)
EV/EBITDA
Interest
15
1,336
Interest/NOPBT